Grant: Discovery Grants Program - Individual
University of Toronto
$64,680.00
Tissue engineering
EF 2011-12
Résumé
The underlying theme of my research program is that biomaterials and the devices based on these materials (e.g., tissue-engineered constructs) are agonists of a biological response. Over the years this theme has manifested itself primarily in the problem of blood compatibility of cardiovascular biomaterials and in the microencapsulation of mammalian cells for the purpose of cell transplantation. Now our efforts are directed towards (1) vascularisation of tissue engineering constructs to circumvent the size limits imposed by Fick's law of diffusion and (2) understanding and controlling the host response to biomaterials. Much of the effort is centered on modular tissue engineering, a novel approach to tissue engineering that results in uniform, scaleable and vascularised constructs. It is based on small (currently cylindrical) modules made from collagen gel or a collagen-poloxamine interpenetrating network, containing embedded cells (e.g., liver cells or pancreatic islets). The modules are then covered with endothelial cells. When filling a space (e.g., a tube or a tissue cavity, in vivo) a packed bed bioreactor is created, in which the endothelial cells enable blood (and hence nutrients) to be perfused. We are currently (i) exploiting the utility of this approach to create fat tissue for post-cancer reconstruction or uniformly contracting sheets of heart muscle cells for the treatment of heart failure or to augment the engraftment of transplanted pancreatic islets and (ii) understanding and controlling the remodelling that occurs when endothelialized modules are implanted in a tissue cavity and subject to the host response The proposed efforts are directed to several of the challenges associated with advancing this concept: for example, (a) further delineation and validation of the design rules (involving Ergun equation; Thiele modulus and Biot number) that underpin the scaleability of the modular approach and (b) evaluation of the phenotype of the endothelial cells in the complex flow arrangements implicit to a packed bed. NSERC support is used to provide the fundamental engineering infrastructure to enable the applied or biomedical studies or as seed money to begin new projects.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
9366-2008
Name nom
Sefton, Michael
Department département
Chemical Engineering and Applied Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2008
Award amount
64680
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
4
Nb partie
5
Application title
Tissue engineering
Keyword
NSERC
Application summary
The underlying theme of my research program is that biomaterials and the devices based on these materials (e.g., tissue-engineered constructs) are agonists of a biological response. Over the years this theme has manifested itself primarily in the problem of blood compatibility of cardiovascular biomaterials and in the microencapsulation of mammalian cells for the purpose of cell transplantation. Now our efforts are directed towards (1) vascularisation of tissue engineering constructs to circumvent the size limits imposed by Fick's law of diffusion and (2) understanding and controlling the host response to biomaterials. Much of the effort is centered on modular tissue engineering, a novel approach to tissue engineering that results in uniform, scaleable and vascularised constructs. It is based on small (currently cylindrical) modules made from collagen gel or a collagen-poloxamine interpenetrating network, containing embedded cells (e.g., liver cells or pancreatic islets). The modules are then covered with endothelial cells. When filling a space (e.g., a tube or a tissue cavity, in vivo) a packed bed bioreactor is created, in which the endothelial cells enable blood (and hence nutrients) to be perfused. We are currently (i) exploiting the utility of this approach to create fat tissue for post-cancer reconstruction or uniformly contracting sheets of heart muscle cells for the treatment of heart failure or to augment the engraftment of transplanted pancreatic islets and (ii) understanding and controlling the remodelling that occurs when endothelialized modules are implanted in a tissue cavity and subject to the host response The proposed efforts are directed to several of the challenges associated with advancing this concept: for example, (a) further delineation and validation of the design rules (involving Ergun equation; Thiele modulus and Biot number) that underpin the scaleability of the modular approach and (b) evaluation of the phenotype of the endothelial cells in the complex flow arrangements implicit to a packed bed. NSERC support is used to provide the fundamental engineering infrastructure to enable the applied or biomedical studies or as seed money to begin new projects.